BMY
Bristol Myers Squibb's second quarter revenue of $13.0B and EPS of $2.04 beat estimates, prompting a raised full-year 2026 outlook.
Bristol Myers Squibb reported second quarter 2026 revenues of $13.0 billion, up 6% year-over-year, and a non-GAAP EPS of $2.04. The results significantly...